1. Home
  2. DXR vs NEPH Comparison

DXR vs NEPH Comparison

Compare DXR & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXR
  • NEPH
  • Stock Information
  • Founded
  • DXR 1970
  • NEPH 1997
  • Country
  • DXR United States
  • NEPH United States
  • Employees
  • DXR N/A
  • NEPH N/A
  • Industry
  • DXR Medical/Dental Instruments
  • NEPH Medical/Dental Instruments
  • Sector
  • DXR Health Care
  • NEPH Health Care
  • Exchange
  • DXR Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • DXR 46.9M
  • NEPH 45.3M
  • IPO Year
  • DXR N/A
  • NEPH 2004
  • Fundamental
  • Price
  • DXR $11.41
  • NEPH $4.34
  • Analyst Decision
  • DXR Strong Buy
  • NEPH Strong Buy
  • Analyst Count
  • DXR 1
  • NEPH 2
  • Target Price
  • DXR $25.00
  • NEPH $5.50
  • AVG Volume (30 Days)
  • DXR 7.9K
  • NEPH 44.2K
  • Earning Date
  • DXR 01-01-0001
  • NEPH 11-06-2025
  • Dividend Yield
  • DXR N/A
  • NEPH N/A
  • EPS Growth
  • DXR 3.46
  • NEPH N/A
  • EPS
  • DXR 0.36
  • NEPH 0.12
  • Revenue
  • DXR $66,306.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • DXR N/A
  • NEPH $24.38
  • Revenue Next Year
  • DXR N/A
  • NEPH $10.16
  • P/E Ratio
  • DXR $32.33
  • NEPH $35.74
  • Revenue Growth
  • DXR N/A
  • NEPH 21.16
  • 52 Week Low
  • DXR $6.55
  • NEPH $1.36
  • 52 Week High
  • DXR $11.70
  • NEPH $5.00
  • Technical
  • Relative Strength Index (RSI)
  • DXR 56.84
  • NEPH 56.18
  • Support Level
  • DXR $11.10
  • NEPH $3.62
  • Resistance Level
  • DXR $11.70
  • NEPH $4.59
  • Average True Range (ATR)
  • DXR 0.50
  • NEPH 0.39
  • MACD
  • DXR 0.00
  • NEPH 0.01
  • Stochastic Oscillator
  • DXR 82.65
  • NEPH 50.05

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: